Project Name：Tigecycline 

Registration Classification：3+6

Formulations and specifications ：Lyophilized preparation: 50mg 

Indications：For adult complicated skin and soft tissue infections (cSSSLs) and adults complicated intra-abdominal infections, including complicated appendicitis , infected burns , intra-abdominal abscesses, deep soft tissue infections and infected ulcers .

Original Research Company：Wyeth Parenterals Division of Wyeth Holdings Corporation. 

Progress ：Pharmaceutical Research in progress